Literature DB >> 23449064

Docking Studies of Adenosine Analogues with NS5 Methyltransferase of Yellow Fever Virus.

Kh Dhanachandra Singh1, Palani Kirubakaran, S Manikandaprabhu, S Nagamani, P Srinivasan, M Karthikeyan.   

Abstract

Yellow fever virus (YFV) is caused by single stranded positive RNA virus called Flavivirus. Till now no specific antiviral agents are available for the treatment of YFV, and despite a commercial YFV vaccine, there are still approximately 30,000 deaths worldwide each year and cases have been increasing in the last 20 years. Here, the effects of adenosine analogues and commercially available adenosine derivative drugs on NS5 methyltransferase of YFV have been performed by the comparative docking study. Based on the docking score, the glide energy and the number of interactions of the adenosine analogues with the Pubchem ID 13792 and 1077 showed the better scoring function than the best ranked commercially available adenosine analogue derived antiviral drug Cc3ado. From the docking result it reveals that these adenosine analogues can bind to the active site of NS5 methyltransferase protein and inhibit the viral replication.

Entities:  

Keywords:  Adenosine analogue; Flavivirus; NS5; Yellow fever virus

Year:  2011        PMID: 23449064      PMCID: PMC3298586          DOI: 10.1007/s12088-011-0201-7

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  14 in total

1.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

Authors:  Thomas A Halgren; Robert B Murphy; Richard A Friesner; Hege S Beard; Leah L Frye; W Thomas Pollard; Jay L Banks
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

2.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  Imported yellow fever in a United States citizen.

Authors:  J M McFarland; L M Baddour; J E Nelson; S K Elkins; R B Craven; B C Cropp; G J Chang; A D Grindstaff; A S Craig; R J Smith
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

4.  Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model.

Authors:  Justin G Julander; John D Morrey; Lawrence M Blatt; Kristiina Shafer; Robert W Sidwell
Journal:  Antiviral Res       Date:  2006-09-22       Impact factor: 5.970

5.  Structure and function of flavivirus NS5 methyltransferase.

Authors:  Yangsheng Zhou; Debashish Ray; Yiwei Zhao; Hongping Dong; Suping Ren; Zhong Li; Yi Guo; Kristen A Bernard; Pei-Yong Shi; Hongmin Li
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

Review 6.  Yellow fever: the recurring plague.

Authors:  Oyewale Tomori
Journal:  Crit Rev Clin Lab Sci       Date:  2004       Impact factor: 6.250

7.  Genetic variability among yellow fever virus 17D substrains.

Authors:  R Galler; P R Post; C N Santos; I I Ferreira
Journal:  Vaccine       Date:  1998 May-Jun       Impact factor: 3.641

Review 8.  Treatment of yellow fever.

Authors:  Thomas P Monath
Journal:  Antiviral Res       Date:  2007-11-20       Impact factor: 5.970

9.  Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay.

Authors:  Hi-Gung Bae; Andreas Nitsche; Anette Teichmann; Stefan S Biel; Matthias Niedrig
Journal:  J Virol Methods       Date:  2003-06-30       Impact factor: 2.014

Review 10.  Inhibitors of virus replication: recent developments and prospects.

Authors:  Julia Magden; Leevi Kääriäinen; Tero Ahola
Journal:  Appl Microbiol Biotechnol       Date:  2004-12-09       Impact factor: 4.813

View more
  1 in total

1.  Novel Elongator Protein 2 Inhibitors Mitigating Tumor Necrosis Factor-α Induced Osteogenic Differentiation Inhibition.

Authors:  Wen-Jiao Wu; Chang-Liang Xia; Shuan-Ji Ou; Yang Yang; Yun-Fei Ma; Yi-Long Hou; Qing-Po Yang; Jun Zhang; Jian-Wei Li; Yong Qi; Chang-Peng Xu
Journal:  Biomed Res Int       Date:  2021-11-22       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.